Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Assess the immunogenicity of 3 doses of Pediarix®, Prevnar® & ActHIB® given to healthy infants when administered with GSK Biologicals’ 2 dose oral live attenuated human rotavirus vaccine given during the same vaccination visit or separately
Rotavirus Vaccine
107531
NCT00334607
Infections, Rotavirus
Phase 3
 
An annotated case report form is not available for this study. A blank case report form will be provided.
January 2014

Powered by ideaPoint, Inc.